Cargando…

Paliperidone ER in the Treatment of Borderline Personality Disorder: A Pilot Study of Efficacy and Tolerability

Antipsychotics are recommended for the treatment of impulsive dyscontrol and cognitive perceptual symptoms of borderline personality disorder (BPD). Three reports supported the efficacy of oral risperidone on BPD psychopathology. Paliperidone ER is the metabolite of risperidone with a similar mechan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bellino, Silvio, Bozzatello, Paola, Rinaldi, Camilla, Bogetto, Filippo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151513/ https://www.ncbi.nlm.nih.gov/pubmed/21826264 http://dx.doi.org/10.1155/2011/680194

Ejemplares similares

Interpersonal Psychotherapy as a Single Treatment for Borderline Personality Disorder: A Pilot Randomized-Controlled Study
por: Bozzatello, Paola, et al.
Publicado: (2020)

Editorial: Borderline Personality Disorders in Adolescents: Clinical Challenges and Recent Advances
por: Bellino, Silvio, et al.
Publicado: (2022)

Early Detection and Outcome in Borderline Personality Disorder
por: Bozzatello, Paola, et al.
Publicado: (2019)

Borderline Personality Disorder: Risk Factors and Early Detection
por: Bozzatello, Paola, et al.
Publicado: (2021)

The Role of Trauma in Early Onset Borderline Personality Disorder: A Biopsychosocial Perspective
por: Bozzatello, Paola, et al.
Publicado: (2021)

The Role of Cognitive Deficits in Borderline Personality Disorder with Early Traumas: A Mediation Analysis
por: Bozzatello, Paola, et al.
Publicado: (2023)

Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia
por: Brasso, Claudio, et al.
Publicado: (2017)

Autobiographical memories, identity disturbance and brain functioning in patients with borderline personality disorder: An fMRI study
por: Bozzatello, Paola, et al.
Publicado: (2019)

Efficacy of Polyunsaturated Fatty Acids (PUFAs) on Impulsive Behaviours and Aggressiveness in Psychiatric Disorders
por: Bellino, Silvio, et al.
Publicado: (2021)

Polyunsaturated Fatty Acids: What is Their Role in Treatment of Psychiatric Disorders?
por: Bozzatello, Paola, et al.
Publicado: (2019)

Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data
por: Bozzatello, Paola, et al.
Publicado: (2016)

Predictive Factors of Treatment Resistance in First Episode of Psychosis: A Systematic Review
por: Bozzatello, Paola, et al.
Publicado: (2019)

Mental Health in Childhood and Adolescence: The Role of Polyunsaturated Fatty Acids
por: Bozzatello, Paola, et al.
Publicado: (2021)

Tolerability and efficacy of paliperidone ER compared to olanzapine in the treatment of schizophrenia: A randomized, double–blind, multicentric trial
por: Shah, Sandip, et al.
Publicado: (2011)

Efficacy and tolerability of paliperidone ER in patients with unsatisfactorily controlled schizophrenia by other antipsychotics: a flexible-dose approach
por: Mauri, Mauro, et al.
Publicado: (2015)

Effects of Omega 3 Fatty Acids on Main Dimensions of Psychopathology
por: Bozzatello, Paola, et al.
Publicado: (2020)

Models Predicting Psychosis in Patients With High Clinical Risk: A Systematic Review
por: Montemagni, Cristiana, et al.
Publicado: (2020)

The Impact of SARS-CoV-2 Infection on Youth Mental Health: A Narrative Review
por: Brasso, Claudio, et al.
Publicado: (2022)

Real-World Functioning in Psychiatric Outpatients: Predictive Factors
por: Bozzatello, Paola, et al.
Publicado: (2022)

Efficacy of Serotonin and Dopamine Activity Modulators in the Treatment of Negative Symptoms in Schizophrenia: A Rapid Review
por: Brasso, Claudio, et al.
Publicado: (2023)

Treatment of Patients with Recently Exacerbated Schizophrenia with Paliperidone Palmitate: A Pilot Study of Efficacy and Tolerability
por: Gattaz, Wagner F, et al.
Publicado: (2020)

Editorial: Psychosis and Personality Disorders: Do We Need Early Diagnosis for Successful Treatment?
por: Bellino, Silvio, et al.
Publicado: (2020)

The relative contributions of insight and neurocognition to intrinsic motivation in schizophrenia
por: Brasso, Claudio, et al.
Publicado: (2022)

Manic Symptoms during a Switch from Paliperidone ER to Paliperidone Palmitate in a Patient with Schizophrenia
por: Demirci, Kadir, et al.
Publicado: (2015)

Paliperidone ER: a review of the clinical trial data
por: Janicak, Philip G, et al.
Publicado: (2007)

PM380. Treatment successful rate and efficacy of Paliperidone ER in patients with acute schizophrenia
por: Chen, Yi-hsing
Publicado: (2016)

Influencing Factors and Predictors of Early Response in Schizophrenia Patients Receiving the Paliperidone Extended-Release Tablets (Paliperidone ER)
por: Jung, Seung-Ho, et al.
Publicado: (2013)

Primary Psychosis: Risk and Protective Factors and Early Detection of the Onset
por: Brasso, Claudio, et al.
Publicado: (2021)

Suicidality in Borderline Personality Disorder
por: Paris, Joel
Publicado: (2019)

Paliperidone to Treat Psychotic Disorders
por: Minwalla, Hormazd D., et al.
Publicado: (2021)

Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient’s Subjective Quality of Life, Well-Being, and Satisfaction
por: Brasso, Claudio, et al.
Publicado: (2023)

Medication adherence in schizophrenia: patient perspectives and the clinical utility of paliperidone ER
por: Birnbaum, Michael, et al.
Publicado: (2008)

Dosing and switching of paliperidone ER in patients with schizophrenia: recommendations for clinical practice
por: Peuskens, Joseph, et al.
Publicado: (2014)

ADHD in adolescents with borderline personality disorder
por: Speranza, Mario, et al.
Publicado: (2011)

Cyclothymic temperament and/or borderline personality disorder
por: Perugi, Giulio
Publicado: (2010)

Social cognition in borderline personality disorder
por: Roepke, Stefan, et al.
Publicado: (2013)

Splitting in Schizophrenia and Borderline Personality Disorder
por: Pec, Ondrej, et al.
Publicado: (2014)

Dissociation in schizophrenia and borderline personality disorder
por: Pec, Ondrej, et al.
Publicado: (2014)

Social Judgement in Borderline Personality Disorder
por: Nicol, Katie, et al.
Publicado: (2013)

Psychopharmacologic treatment of borderline personality disorder
por: Ripoll, Luis H.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_381s6kbbgtibf0r4l6o8o73p2q